---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-051292"
form_type: "8-K"
ticker: "DRIO"
cik: "0001533998"
company_name: "DarioHealth Corp."
filed_at: "2025-05-21T23:59:59+00:00"
generated_at: "2026-05-20T22:28:25.719033+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# DarioHealth extends mandatory conversion period for Series C preferred stock from 15 to 24 months

## Summary
- Mandatory conversion period extended from 15 to 24 months for Series C, C-1, C-2 preferred stock.
- Preferred holders will receive a quarterly dividend of 15% of common shares issuable upon conversion.
- No new securities were issued or sold as a result of the amendment.
- Amended and restated certificates of designation filed on May 20, 2025.

## SEC filing metadata
- accession: 0001104659-25-051292
- form_type: 8-K
- ticker: DRIO
- cik: 0001533998
- company_name: DarioHealth Corp.
- filed_at: 2025-05-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533998/000110465925051292/0001104659-25-051292-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533998/000110465925051292/tm2515738d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-051292
- JSON: https://secwatch.observer/filing/0001104659-25-051292.json
- Plain text: https://secwatch.observer/filing/0001104659-25-051292.txt

## Key facts
- Governance Changes
  DarioHealth Corp.: Amended the Series C, C-1, and C-2 Certificates of Designation to extend the mandatory conversion period from 15 to 24 months and add a quarterly dividend of 15% of Common Stock issuable upon conversion (effective 2025-05-20).
  - Change: charter amendment
  - Effective: 2025-05-20
  source text: On May 20, 2025, DarioHealth Corp. (the “Company”), upon obtaining the vote of a majority of the holders of the relevant classes of preferred stock, filed an Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of the Company’s Series C Preferred Stock
  evidence_url: https://www.sec.gov/Archives/edgar/data/1533998/000110465925051292/0001104659-25-051292-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
